menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.

Rethink: Channel Strategy for Oral Oncolytics

By AmerisourceBergen

Enabling access and supporting adherence at the most appropriate site of care improves more than patient satisfaction—it improves outcomes.

Is it time to rethink channel strategy for oral oncology therapies?

In this ebook, you'll learn:

  • How health systems and community oncology practices are growing their capabilities around specialty dispensing
  • The impact on patients when oral oncolytics are launched in limited networks
  • New models for prioritizing patient access and filling gaps in SP data
  • The role your distributor plays in optimizing access to treatment for cancer patients